M

Mirae Asset Capital portfolio

Mirae Asset Capital has 6 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Precision Neuroscience's $250M Series B+ round in September 2026, alongside B Capital, ARK Investment Management, Mubadala Capital Ventures and 6 others. By category, its portfolio leans toward Health and bio (2) and Developer tools and cloud (2). It has co-invested with Hitachi Ventures, B Capital and Invus, most often Hitachi Ventures (2 rounds).

What Mirae Asset Capital invests in

• Health and bio · 2 · 33%
• Developer tools and cloud · 2 · 33%
• Commerce and retail · 2 · 33%
• Robotics and hardware · 1 · 17%
• Manufacturing and industrial · 1 · 17%
• AI infrastructure and compute · 1 · 17%

Mirae Asset Capital recent investments

Company	Round	Date	Alongside
PPrecision Neuroscience	Series B+ · $250M	Sep 24, 2026	B Capital, ARK Investment Management, Mubadala Capital Ventures +6
AApex	Series B+ · $95M	Jun 12, 2024	XYZ Venture Capital (lead), Upfront Ventures, Toyota Ventures +6
WWEKA	Series B+ · $135M	Nov 15, 2022	Samsung Catalyst Fund, Qualcomm Ventures, Nvidia +6
AAspen Neuroscience	Series B+ · $147.5M	May 18, 2022	S32, Revelation Partners (lead), OrbiMed +6

How Mirae Asset Capital invests

Share is of the 4 rounds on Recent Funding that name Mirae Asset Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Mirae Asset Capital portfolio companies

• PPrecision Neuroscience$250MSeries B+ · Sep 2026
• AApex$95MSeries B+ · Jun 2024
• WWEKA$135MSeries B+ · Nov 2022
• AAspen Neuroscience$147.5MSeries B+ · May 2022
• AApeel Sciencesbacker
• BBucketplacebacker

Company	Round with Mirae Asset Capital	Total raised	Latest raise
PPrecision Neuroscience Health and bio	Sep 24, 2026 Series B+ · $250M	$303M	Sep 24, 2026 Series B+
AApex Robotics and hardware	Jun 12, 2024 Series B+ · $95M	$311M	Apr 29, 2025 Series B+
WWEKA AI infrastructure and compute	Nov 15, 2022 Series B+ · $135M	$275M	May 15, 2024 Series B+
AAspen Neuroscience Health and bio	May 18, 2022 Series B+ · $147.5M	$115M	Nov 20, 2025 Series B+
AApeel Sciences Commerce and retail	backer	$250M	Oct 22, 2025 Series B+
BBucketplace Commerce and retail	backer	$182M	May 9, 2022 Series B+

Most frequent co-investors

• HHitachi Ventures2 shared rounds · last Sep 24, 2026
• BB Capital1 shared round · last Sep 24, 2026
• IInvus1 shared round · last Sep 24, 2026
• AARK Investment Management1 shared round · last Sep 24, 2026
• KKorea Investment Partners1 shared round · last Sep 24, 2026
• MMubadala Capital Ventures1 shared round · last Sep 24, 2026
• DDuquesne Family Office1 shared round · last Sep 24, 2026
• PPershing Square Inc.1 shared round · last Sep 24, 2026
• JJSL Health Capital1 shared round · last Sep 24, 2026
• UUpfront Ventures1 shared round · last Jun 12, 2024
• PPoint72 Ventures1 shared round · last Jun 12, 2024
• TToyota Ventures1 shared round · last Jun 12, 2024

Similar investors

• SSauce VC6 companies · 6 deals in 12 mo
• AAlteria Capital6 companies · 5 deals in 12 mo
• IInflection Point Ventures6 companies · 4 deals in 12 mo
• BBlockchange Ventures6 companies · 3 deals in 12 mo
• KKaszek6 companies · 1 deal in 12 mo
• AAlpha Wave Global6 companies

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Mirae Asset Capital, which is a subset of its real portfolio. API: /api/v1/investors/mirae-asset-capital (get a free API key). More: the most active VC firms and new venture capital funds.